Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Roger E. WysePresident and Chief Operating Officer, Burrill Biogreentech Venture and Private Equity Funds
Roger E. Wyse joined Burrill & Company in 1998 and has led the development of its agriculture, nutraceuticals, health and wellness, and biogreentechrelated activities in venture capital investing, and merchant banking.
Dr. Wyse is an internationally recognized scientist and was a Dean at two major research universities. He served for five years as Dean of the
He has published more than 150 scientific papers. In recognition of his research accomplishments he received the prestigious Arthur Flemming Award in 1982 as the Outstanding Young Scientist in the U.S. Federal Service. He was elected a Fellow of both the Crop Science Society of America and The American Society of Agronomy. And in 2008, he was elected as a Fellow of The American Association for the Advancement of Science. He has also served as a consultant to numerous Fortune 500 companies.